![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 213/74 | |
C07D 213/75 | |||
C07D 213/81 | |||
C07D 213/82 | |||
C07D 237/20 | |||
C07D 239/42 | |||
C07D 263/48 | |||
C07D 277/42 | |||
C07D 401/10 | |||
C07D 401/12 | |||
C07D 401/14 | |||
C07D 405/12 | |||
C07D 413/10 | |||
C07D 413/12 | |||
A61K 31/44 | |||
A61K 31/50 | |||
A61K 31/53 | |||
A61K 31/421 | |||
A61K 31/426 |
(11) | Number of the document | 2418202 |
(13) | Kind of document | T |
(96) | European patent application number | 11158211.0 |
Date of filing the European patent application | 2007-03-28 | |
(97) | Date of publication of the European application | 2012-02-15 |
(45) | Date of publication and mention of the grant of the patent | 2014-01-29 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
787859 P | 2006-03-31 | US |
(72) |
Serrano-Wu, Michael H, US
Kwak, Young-Shin, US
Liu, Wenming, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors |
(4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors |